{"result": {"id": "d453f813-5d14-4f8d-b014-98eb73980f80", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>JAtherosclerThromb<|>organization<|>A journal publishing research on atherosclerosis and thrombosis\")  \n##  \n(\"entity\"<|>Arch Intern Med<|>organization<|>A medical journal publishing internal medicine research\")  \n##  \n(\"entity\"<|>J Hypertens<|>organization<|>A journal focused on hypertension research\")  \n##  \n(\"entity\"<|>中华医学会心血管病学分会<|>organization<|>Chinese Medical Association's Cardiovascular Branch, involved in cardiovascular disease prevention guidelines\")  \n##  \n(\"entity\"<|>中国康复医学会心脏预防与康复专业委员会<|>organization<|>Chinese Association of Rehabilitation Medicine's Cardiac Prevention and Rehabilitation Committee\")  \n##  \n(\"entity\"<|>中国老年学和老年医学会心脏专业委员会<|>organization<|>Chinese Geriatrics Society's Cardiac Committee\")  \n##  \n(\"entity\"<|>World Health Organization-International Society of Hypertension (WHO-ISH)<|>organization<|>Collaborative body setting global hypertension management guidelines\")  \n##  \n(\"entity\"<|>European Society of Hypertension (ESH)<|>organization<|>European organization involved in hypertension guidelines\")  \n##  \n(\"entity\"<|>European Society of Cardiology (ESC)<|>organization<|>European organization involved in cardiovascular guidelines\")  \n##  \n(\"entity\"<|>Blood Pressure Lowering Treatment Trialists' Collaboration<|>organization<|>Research group analyzing blood pressure treatment effects\")  \n##  \n(\"entity\"<|>Murabito JM<|>person<|>Researcher involved in the Framingham study on ankle-brachial index\")  \n##  \n(\"entity\"<|>Bo Y<|>person<|>Researcher involved in a meta-analysis on ambulatory blood pressure monitoring\")  \n##  \n(\"entity\"<|>Kang YY<|>person<|>Researcher studying home vs. ambulatory blood pressure monitoring\")  \n##  \n(\"entity\"<|>张宇清<|>person<|>Co-author of Chinese hypertension prevention guidelines\")  \n##  \n(\"entity\"<|>刘国仗<|>person<|>Co-author of Chinese hypertension prevention guidelines\")  \n##  \n(\"entity\"<|>Williams B<|>person<|>Contributor to ESC/ESH hypertension guidelines\")  \n##  \n(\"entity\"<|>Mancia G<|>person<|>Key figure in ESH/ESC hypertension guidelines\")  \n##  \n(\"entity\"<|>Framingham study<|>event<|>Longitudinal study on cardiovascular risk factors\")  \n##  \n(\"relationship\"<|>中华医学会心血管病学分会<|>中国康复医学会心脏预防与康复专业委员会<|>Both organizations collaborated on China's cardiovascular prevention guidelines<|>7\")  \n##  \n(\"relationship\"<|>World Health Organization-International Society of Hypertension (WHO-ISH)<|>European Society of Hypertension (ESH)<|>Both organizations develop hypertension management guidelines<|>6\")  \n##  \n(\"relationship\"<|>European Society of Hypertension (ESH)<|>European Society of Cardiology (ESC)<|>Joint task force for arterial hypertension management<|>8\")  \n##  \n(\"relationship\"<|>张宇清<|>刘国仗<|>Co-authors of Chinese hypertension prevention guidelines<|>7\")  \n##  \n(\"relationship\"<|>Mancia G<|>European Society of Hypertension (ESH)<|>Mancia G is a key contributor to ESH guidelines<|>8\")  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558863, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 758, "prompt_tokens": 2894, "total_tokens": 3652, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 1102}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ofthe artreview: brachial-ankle PWV[J]. JAtherosclerThromb,2020,27(7) :621-636.\n[122]  MurabitoJM, EvansJC, Larson MG, etal. Theankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham study[J]. Arch Intern Med, 2003, 163\n(16) :1939-1942.\n[123]  BoY, Kwok KO, ChungVC, etal. Short-term reproducibility ofambulatory blood pressure measurements:  a systematic re- view and meta-analysisof35 observationalstudies[J]. J Hyper- tens,2020,38(11) :2095-2109.\n[124]  KangYY, LiY, Huang QF, et al.  Accuracy of home versus ambulatoryblood pressuremonitoringin thediagnosisofwhite- coatand masked hypertension[J]. J Hypertens, 2015, 33(8) :  1580-1587.\n[125]  中华医学会心血管病学分会 , 中国康复医学会心脏预防与康复  专业委员会 , 中国老年学和老年医学会心脏专业委员会 ,等.  中  国心血管 病 一 级 预 防 指 南 [J]. 中 华 心 血 管 病 杂 志 , 2020, 48\n(12) :1000-1038.\n[126]  张宇清 ,刘国仗.《中国高血压防治指南》(试行本摘要) [J]. 中华 内科杂志 ,2000,39(2) :140-144.\n[127]  Guidelines Subcommittee of the World Health Organization-In- ternationalSociety of Hypertension (WHO-ISH) Mild Hyper- tensionLiaisonCommittee.  1999WorldHealthOrganization-In-\n\n\n\n　ternationalSociety of Hypertension guidelines for the manage- mentofhypertension[J]. J Hypertens,1999,17(2) :151-183.\n[128]  WilliamsB, Mancia G, SpieringW, etal. 2018ESC/ESH guide- linesforthemanagementofarterialhypertension[J]. Eur Heart J,2018,39(33) :3021-3104.\n[129]  UngerT, BorghiC, CharcharF, etal. 2020InternationalSoci- ety ofHypertensionglobalhypertension practiceguidelines[J]. J Hypertens,2020,38(6) :982-1004.\n[130]  Mancia G,  Fagard R, Narkiewicz K,  et al.  2013 ESH/ESC guidelinesforthemanagementofarterialhypertension: thetask forceforthemanagementofarterialhypertensionoftheEurope- an SocietyofHypertension(ESH) and ofthe European Society ofCardiology(ESC)[J]. J Hypertens,2013,31(7) :1281-1357.\n[131]  ShengY, LiM, XuM, etal. Leftventricularandatrialremod- ellinginhypertensivepatientsusingthresholdsfrom internation- alguidelinesandEMINCA data[J]. EurHeartJCardiovascIma- ging,2022,23(2) :166-174.\n[132]  Zhou D, Yan M, CaiA, et al.  Prognostic implications of left ventricularhypertrophydefinedbythethresholdsfrom theinter- nationaland Chinese guidelines[J]. J Clin Hypertens (Green- wich) ,2023,25(7) :628-637.\n[133]  ThomopoulosC, ParatiG, ZanchettiA.  Effects ofblood pres- surelowering on outcome incidence in hypertension: 7.  Effects ofmorevs.  less intensive blood pressure lowering and different achieved blood pressurelevels-updated overview and meta-ana- lyses of randomized trials[J]. J Hypertens, 2016, 34(4) : 613- 622.\n[134]  Blood Pressure Lowering Treatment Trialists'Collaboration.  Phar- macologicalblood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: anindividualparticipant-leveldatameta-analysis [J]. Lancet,2021,397(10285) :1625-1636.\n[135]  EttehadD, EmdinCA, KiranA, etal. Bloodpressurelowering forprevention ofcardiovasculardisease and death: a systematic review and meta-analysis[J]. Lancet, 2016, 387(10022) : 957- 967.\n[136]  Brunstr?m M, CarlbergB.  Associationofbloodpressurelower- ing with mortality and cardiovasculardisease across blood pres- surelevels: asystematicreview andmeta-analysis[J]. JAMA In- tern Med,2018,178(1) :28-36.\n[137]  LonnEM, BoschJ, López-JaramilloP, etal. Blood-pressurelower- ing in intermediate-risk persons without cardiovascular disease [\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_a9f764901977e14167c2843f3d5370c17b7217f21c800b2058d79b78cca77d95_v2"}